German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment

Contributed by: Business Wire

Logo

Images

The ProtEmbo Cerebral Embolic Protection system in the Aortic Arch (Graphic: Business Wire)

Business Wire embedded0

Tags

Other Health

Other Science

Research

Venture Capital

Finance

Medical Devices

Hospitals

Professional Services

Science

Clinical Trials

Medical Supplies

Cardiology

General Health

FDA

Biotechnology

Health

Small Business

Health Technology

Medtech

More Like This

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

Business Wire associated0

Protembis Announces Formation of New Scientific Advisory Board Comprised of World-Renowned Structural Heart Experts

PR Newswire associated0

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

PR Newswire associated0

Emboline Prevails in German Utility Model Infringement Action Against AorticLab

Emboline, Inc. Files Patent Infringement Suit Against AorticLab s.r.l. Regarding Embolic Protection Medical Device